Loading…
ENDRA Life Sciences Inc. is projected to rise to $6.76 by 2027, a +26% move from its current price of $5.36. NDRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.09 | $5.36 | $5.63 | -0.07% |
| May 30 | $4.99 | $5.35 | $5.75 | -0.14% |
| May 31 | $4.90 | $5.35 | $5.83 | -0.22% |
| Jun 1 | $4.83 | $5.34 | $5.91 | -0.29% |
| Jun 2 | $4.77 | $5.34 | $5.98 | -0.36% |
| Jun 3 | $4.72 | $5.34 | $6.04 | -0.43% |
| Jun 4 | $4.67 | $5.33 | $6.09 | -0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.67 | $5.33 | $6.09 | -0.50% |
| Week 2 | $4.40 | $5.31 | $6.40 | -1.00% |
| Week 3 | $4.19 | $5.28 | $6.65 | -1.50% |
| Week 4 | $4.03 | $5.25 | $6.85 | -2.00% |
| Week 5 | $3.88 | $5.23 | $7.03 | -2.49% |
| Week 6 | $3.76 | $5.20 | $7.20 | -2.98% |
| Week 7 | $3.64 | $5.17 | $7.35 | -3.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ENDRA Life Sciences Inc. is a healthcare company focused on advancing clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that uses pulsed energy sources such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis.
ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
The description reflects ENDRA’s focus on ultrasound-based imaging technologies within the healthcare sector, applying these capabilities to diagnostic and imaging workflows.
ENDRA Life Sciences Inc. trades with the current price of $5.46 and a market cap of $6.93M, ranking 5260 in market listings. The stock is characterized by a near-term price range that reflects modest liquidity and a high-variance environment, with a 30-day range of $3.87 to $7.70.
Near-term forecasts show a path of potential upside from a 2026 baseline, with the 2026 average price projected at $5.46 and bullish momentum developing in subsequent years. The sequence of annual averages rises through 2029 and beyond, with 2040 and 2050 forecasts projecting substantially higher levels. Specifically, the forecast provides year-by-year averages including 2027 at $6.83, 2028 at $7.91, 2029 at $8.01, 2030 at $7.74, 2032 at $6.94, 2033 at $9.50, 2034 at $9.49, 2035 at $10.27, 2040 at $13.33, and 2050 at $17.41.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.5% below — buyers have tended to step in here.
The nearest ceiling, 19.4% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key NDRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NDRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.38 | Sell | $5.36 | Sell |
| MA 10 | $5.44 | Sell | $5.36 | Buy |
| MA 20 | $5.22 | Buy | $5.27 | Buy |
| MA 50 | $4.89 | Buy | $4.97 | Buy |
| MA 100 | $4.44 | Buy | $4.87 | Buy |
| MA 200 | $4.87 | Buy | $19.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.97 | Neutral |
| Stoch RSI (14) | 19.28 | Buy |
| CCI (20) | 31.31 | Neutral |
| Williams %R (14) | -52.33 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 8.28 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 47.67 | Neutral |
| TRIX (15) | 0.45 | Buy |
| Awesome (5,34) | 0.16 | Buy |
| Ultimate (7,14,28) | 59.20 | Neutral |
| Momentum (10) | -0.45 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 5.31 | Buy |
| ADX (14) | 11.67 | Neutral |
| ATR (14) | 0.22 | Info |
The near-term technical picture remains bullish with RSI at 50. The stock trades with a 50-day simple moving average of $4.81 and a 200-day simple moving average of $4.86. Support sits at $4.59 and resistance at $6.40, framing a relatively wide near-term trading band.
The 30-day price range is $3.87 to $7.70, indicating meaningful volatility within a month-long window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.26 | $5.36 | $6.92 | 0% | Neutral | |
| $4.92 | $6.76 | $10.02 | +26% | Bullish | |
| $5.30 | $7.68 | $12.08 | +43% | Bullish | |
| $5.12 | $7.78 | $12.80 | +45% | Bullish | |
| $4.84 | $7.69 | $13.13 | +43% | Bullish | |
| $3.58 | $5.91 | $10.43 | +10% | Neutral | |
| $3.96 | $6.80 | $12.35 | +27% | Bullish | |
| $5.28 | $9.40 | $17.53 | +75% | Bullish | |
| $5.07 | $9.35 | $17.86 | +74% | Bullish | |
| $5.25 | $10.04 | $19.60 | +87% | Bullish | |
| $5.89 | $13.09 | $27.98 | +144% | Bullish | |
| $7.78 | $17.29 | $39.76 | +223% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.26 | $5.36 | $6.39 | +0.00% |
| June 2026 | $4.48 | $5.36 | $6.63 | -0.00% |
| July 2026 | $4.13 | $5.02 | $6.36 | -6.35% |
| August 2026 | $4.19 | $5.16 | $6.66 | +2.75% |
| September 2026 | $4.39 | $5.46 | $7.16 | +5.93% |
| October 2026 | $4.14 | $5.20 | $6.90 | -4.82% |
| November 2026 | $3.86 | $4.89 | $6.57 | -5.94% |
| December 2026 | $3.99 | $5.10 | $6.92 | +4.24% |
Click any year to see its month-by-month NDRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
ENDRA Life Sciences Inc.'s 2026 outlook centres on $5.36, within a $3.26 to $6.92 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, NDRA could reach as high as $10.02, with a base case around $6.76 and support toward $4.92 — roughly +26% from $5.36. Buyers look set to stay in control over this stretch.
Expect NDRA to range from $5.30 to $12.08 through 2028. The $7.68 average target implies a +43% move from current prices. That is up +14% on the projected 2027 average. Momentum favours further upside here.
The NDRA price prediction for 2029 points to an average of $7.78 (low $5.12, high $12.80) — a potential gain of +45% on today's $5.36. Buyers look set to stay in control over this stretch.
In 2030, NDRA is projected to trade between $4.84 and $13.13, averaging $7.69 — a potential gain of +43% from today's $5.36. That is -1% versus the projected 2029 average. Momentum favours further upside here.
ENDRA Life Sciences Inc.'s 2031 outlook centres on $5.91, within a $3.58 to $10.43 range. That is -23% versus the projected 2030 average. That marks a +10% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, NDRA could reach as high as $12.35, with a base case around $6.80 and support toward $3.96 — roughly +27% from $5.36. Momentum favours further upside here.
Expect NDRA to range from $5.28 to $17.53 through 2033. The $9.40 average target implies a +75% move from current prices. That is up +38% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The NDRA price prediction for 2034 points to an average of $9.35 (low $5.07, high $17.86) — a potential gain of +74% on today's $5.36. Momentum favours further upside here.
In 2035, NDRA is projected to trade between $5.25 and $19.60, averaging $10.04 — a potential gain of +87% from today's $5.36. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
ENDRA Life Sciences Inc.'s 2040 outlook centres on $13.09, within a $5.89 to $27.98 range. That is up +30% on the projected 2035 average. That marks a +144% change versus current levels. Momentum favours further upside here.
By 2050, NDRA could reach as high as $39.76, with a base case around $17.29 and support toward $7.78 — roughly +223% from $5.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in NDRA today (≈ 186.567164 NDRA) could be worth
$3,224.98
+$2,224.98 (+222%) by 2050 · US Dollar
Based on the average projected NDRA price of $17.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NDRAwould be worth at today's price.
$1,000 invested in NDRA on May 27, 2025 (≈ 315.457406 NDRA) would be worth
$1,690.85
+$690.85 (+69.1%) today · 1.69× · US Dollar
Based on a NDRA entry price of $3.17 vs. today's $5.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.55 | $965.77 | -3.4% |
| 1 month ago | $4.82 | $1,112.03 | +11.2% |
| 3 months ago | $3.92 | $1,367.35 | +36.7% |
| 6 months ago | $5.91 | $906.94 | -9.3% |
| 1 year ago | $3.17 | $1,690.85 | +69.1% |
| All time (5.0y) ago | $72,800 | $0.07 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NDRA forecast.
Our base-case forecast reaches $11.00 around 2040.
Implied market cap at $11.00: $13.97M
Looking across the multi-year forecast, 2030 shows an average price of $7.74 with a 41.8% ROI and bullish sentiment, suggesting a material step up from the current level. The forecast continues to reflect upside potential into 2040, with an average price of $13.33 and a 144.1% ROI, still described as bullish. By 2050, the average is projected at $17.41 with a 218.8% ROI and bullish sentiment, signaling strong long-run upside potential despite the inherent uncertainty of forecast modeling.
Beyond the 2030, 2040, and 2050 anchors, the path includes several other bullish years (e.g., 2033 with a 73.9% ROI and 2034 with 73.8%, 2035 with 88.2%), interspersed with neutral years (e.g., 2026 and 2031). These numbers are estimates and not guarantees, reflecting a range of possible outcomes under varying conditions.
Tap a question to reveal the answer.
The forecast shows an avg of $7.74 with a min of $4.81 and a max of $13.39; ROI is 41.8%; sentiment bullish.
The forecast includes multiple years labeled bullish with positive ROIs (e.g., 25.1% in 2027, 44.9% in 2028, 46.7% in 2029, 41.8% in 2030, 27% in 2032, 73.9% in 2033, 73.8% in 2034, 88.2% in 2035, 144.1% in 2040, and 218.8% in 2050), alongside neutral years (e.g., 2026, 2031). These are estimates and not guarantees.
Yes. The 2030 forecast lists a max of $13.39, with an average of $7.74 and a min of $4.81.
Current price is $5.46 and market cap is $6.93M.
By 2040, the average is projected at $13.33 with a 144.1% ROI and bullish sentiment; by 2050, the average is $17.41 with a 218.8% ROI and bullish sentiment.
ENDRA Life Sciences Inc. Community Discussion
0Share your ENDRA Life Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.